Pyrazoloacridine Withdrawn Phase 2 Trials for Metastatic Cancer / Liver Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00003714 | Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer |